12th pharmacovigilance stakeholder forum

EventHumanRegulatory and procedural guidancePharmacovigilance

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Date: Monday, 24 September 2018, All day
Location: European Medicines Agency, Amsterdam, the Netherlands

This forum brings together regulators with patients, healthcare professionals and the pharmaceutical industry, to take stock of what we have achieved and what needs to be the focus over the coming years.

Video

Documents

Agenda – 12th Pharmacovigilance stakeholder forum

Reference Number: EMA/274125/2018

English (EN) (75.95 KB - PDF)

First published: 19/09/2018 Last updated: 02/10/2018

List of participants: 12th stakeholder forum on the pharmacovigilance legislation

Reference Number: EMA/505196/2018

English (EN) (83.22 KB - PDF)

First published: 05/10/2018

Presentation - Pharmacovigilance in 2018 (P. Arlett)

English (EN) (2.56 MB - PDF)

First published: 05/10/2018

Presentation - Overview of current patient involvement (M. Mavris)

English (EN) (1.15 MB - PDF)

First published: 08/10/2018

Presentation - Public Hearings; experience so far (N. Bere)

English (EN) (318.9 KB - PDF)

First published: 08/10/2018

Presentation - The engagement of patients and healthcare professionals in regulatory pharmacovigilance: developing a conceptualisation (P. Brown)

English (EN) (1.18 MB - PDF)

First published: 08/10/2018

Presentation - Valproate case study: industry perspective (E. Teo)

English (EN) (172.44 KB - PDF)

First published: 08/10/2018

Presentation - Public hearing on valproate: Account of events and outcomes (E. Vatzaki)

English (EN) (181.97 KB - PDF)

First published: 08/10/2018

Presentation - Valproate case study: patients' perspective (F.Houyez)

English (EN) (2.84 MB - PDF)

First published: 08/10/2018

Presentation - Valproate case study: pharmacists' perspective (R. Anderson)

English (EN) (892.25 KB - PDF)

First published: 08/10/2018

Presentation - Valproate case study: doctors' perspective (R. Kalvianen)

English (EN) (921.29 KB - PDF)

First published: 08/10/2018

Presentation - Valproate case study: engagement of patients and healthcare professionals (P. Bahri)

English (EN) (245.16 KB - PDF)

First published: 08/10/2018

Presentation - Pharmacovigilance in the next 5 years, doctors' vision (C. Matias)

English (EN) (730.35 KB - PDF)

First published: 08/10/2018

Presentation - Pharmacovigilance in the next 5 years, pharmacists' vision (J. De Belie)

English (EN) (658.34 KB - PDF)

First published: 08/10/2018

Presentation - Pharmacovigilance in the next 5 years, industry vision (V. Edwards)

English (EN) (1.12 MB - PDF)

First published: 08/10/2018